Stock AnalizOmega Healthcare Investors Inc. OHI
Real Estate Investment Trusts · IPO 1992 · data as of November 13, 2026
Omega Healthcare Investors Inc. (OHI) is a real estate company listed in the US with a market value of about $14.3B. In the twelve months to September 30, 2026 it had revenue of $1.3B and net income of $746M, a net margin of 56.9%.
Its overall Stock Analiz score is 3.0 out of 5 (average). The strongest part is value (4/5); the weakest is track record (2/5).
Key numbers: a P/E of 19.0, a price to free cash flow of 18.4, 5-year revenue growth of 6% a year. A discounted cash flow model with moderate assumptions puts its intrinsic value about 50% below the current price.
Score: 3.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
- ROE above 15%
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.1B | $950M | $878M | $1.1B | $892M | $929M | $882M | $908M | $901M |
| Net income | $746M | $590M | $406M | $242M | $427M | $417M | $159M | $341M | $282M | $100M | $366M |
| Free cash flow | $777M | $798M | $712M | $580M | $579M | $677M | $677M | $501M | $470M | $540M | $584M |
| EPS (diluted) | $2.48 | $1.94 | $1.55 | $1.00 | $1.80 | $1.75 | $0.70 | $1.58 | $1.40 | $0.51 | $1.90 |
| Net margin | 56.9% | 49.6% | 38.6% | 25.5% | 48.6% | 39.2% | 17.8% | 36.7% | 31.9% | 11.1% | 40.7% |
| ROIC | — | — | — | — | — | — | — | 5.9% | 6.2% | 3.8% | 6.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 19 analysts is $51.68, 10% above the current price; targets range from $46.00 to $61.00; the consensus rating is “Buy”; expected EPS is $2.53 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Omega Healthcare Investors’s P/E ratio?
About 19.0, based on the last twelve months of diluted earnings per share (forward P/E about 24.3).
Is Omega Healthcare Investors stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 50% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Omega Healthcare Investors pay a dividend?
Yes. The dividend yield is about 5.65%, and it has paid dividends for 10 years in our data.
Is Omega Healthcare Investors a good stock to buy?
We do not give buy or sell advice. Omega Healthcare Investors scores 3.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.